Navigating the Pricing Regulation for Pharmaceuticals and Medical Devices in India – Part B [Podcast]
Friday, July 14, 2023
drugs galore

Related Practices & Jurisdictions
Print Mail Download i

In the second episode of this two-part series, Dr. Milind Antani, Darren Punnen and Varsha Rajesh discuss recent developments to the price control regime for medical devices and pharmaceutical companies in India.

 

Nishith Desai Associates 2024. All rights reserved.

Current Legal Analysis

More from Nishith Desai Associates

Incorporation of Arbitral Clause by Reference: Position in India and Other Asian Jurisdictions
by: Vyapak Desai , Nishanth Kadur
Delhi High Court: Violating Arbitral Procedure May Warrant Anti-Arbitration Injunction
by: Ritika Bansal , Arjun Gupta
Soaring High on Hoverbikes: Look Ma, No Ground!
by: Dr. Mihir A. Parikh
Duplicating with Digital Twins: Two Peas in a Pod One Real, One Virtual
by: Dr. Mihir A. Parikh , Muqeet Drabu
Synchronizing with Cyborgs: Who Am I – Human or Machine?
by: Dr. Mihir A. Parikh , Tanya Kukade
Unlocking India's Space Potential: India Liberalizes Foreign Direct Investment Regime
by: Huzefa Tavawalla , Ayushi Pandey
Cost-To-Cost Reimbursement Held to Be Taxable in Absence of Documentary Evidence
by: Muqeet Drabu , Morvi Chaturvedi
Exit by Investors: Navigating Contractual and Statutory Routes
by: Soumya Gulati , Shruti Dhonde
Privacy and Data Protection in India: 2024 Watchlist and 2023 Wrap
by: Varsha Rajesh , Purushotham Kittane
India’s Securities Regulator Revisits Market Rumour Verification Regime for Listed Companies
by: Ratnadeep Roychowdhury , Anurag Shah

Upcoming Legal Education Events

 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins